CME GROUP INC CLASS A (CME)
Sector: Financials
2026 Annual Meeting Analysis
CME GROUP INC CLASS A · Meeting: May 14, 2026
Directors FOR
14
Directors AGAINST
0
Say on Pay
FOR
Auditor
FOR
Director Elections
Election of Equity Directors
CME's 3-year stock return of +85.7% outpaces the disclosed compensation peer group median of +39.7% by +46.0 percentage points, well below the 65pp threshold needed to trigger a concern for a company with strong positive returns; no overboarding, attendance, or independence issues identified.
Joined in 2023 (within 24 months of this meeting), so she is exempt from the TSR underperformance trigger; brings strong audit and financial services expertise as a CPA and former Deloitte partner, and serves on appropriate committees.
CME outperforms its peer group by +46.0pp over 3 years, far below the 65pp trigger threshold; director brings deep financial markets and government experience with no independence, attendance, or overboarding concerns.
No TSR underperformance trigger fires — CME's 3-year outperformance vs. peers (+46.0pp) is well under the 65pp threshold; long-tenured director with deep derivatives industry experience serving as independent Lead Director.
No TSR trigger applies; director brings over 30 years of CME Group and CBOT operational and regulatory experience with no independence, attendance, or overboarding concerns.
Joined in 2023 (within 24 months), exempt from TSR trigger; brings valuable financial services, government relations, and public policy experience with no overboarding concerns identified.
No TSR trigger applies; long-tenured director with deep knowledge of CME's exchange operations, market regulation, and industry history with no attendance or independence issues.
No TSR trigger applies; serves on two additional public company boards (AllianceBernstein and Equitable Holdings), which is within the four-board limit; brings significant audit, financial services, and corporate governance expertise as an audit committee financial expert.
No TSR trigger applies; brings innovation, technology, and leadership experience; serves on Federal Home Loan Bank of Chicago board which is not a public company board for overboarding purposes, so no overboarding concern.
No TSR trigger applies; brings deep expertise in financial economics, derivatives, fixed income, and government financial policy directly relevant to CME's business with no independence or attendance concerns.
No TSR trigger applies; brings technology, privacy, cybersecurity, and M&A legal expertise from Google and prior law firm experience, with no overboarding or attendance concerns.
No TSR trigger applies; brings long-standing futures industry and clearing house oversight experience; no public company overboarding concern identified.
No TSR trigger applies; brings extensive clearing house risk management and market participant knowledge through decades of experience with CME's exchange operations.
No TSR trigger applies; serves on one public company board (Dime Community Bancshares), within limits; brings Goldman Sachs commodities derivatives and risk management expertise with significant corporate governance experience.
CME's 3-year stock return of +85.7% outperforms the company's disclosed compensation peer group median of +39.7% by +46.0 percentage points, which is well below the 65-percentage-point threshold required to trigger a concern for a company with strong positive returns. No directors have overboarding issues, attendance problems, or independence concerns that would warrant a vote against. All 14 equity director nominees receive a FOR vote.
Say on Pay
✓ FORCEO
Terrence A. Duffy
Total Comp
$23,394,854
Prior Support
N/A
CEO total compensation of approximately $23.4 million is substantial but reflects a pay structure where fixed salary ($2 million) represents only about 9% of total pay, well within the 40% ceiling — the vast majority of pay is variable and performance-linked. The company's stock returned +85.7% over three years, outpacing its disclosed peer group median by +46.0 percentage points, and performance shares tied to the 2023-2025 period paid out at 200% of target after CME ranked at the 78.8th percentile of the S&P 500 on total shareholder return — a clear example of incentive pay aligned with strong shareholder outcomes. The compensation program includes meaningful performance conditions (relative TSR and absolute net income margin), a robust clawback policy, and stock ownership requirements, with no red flags in pay structure.
Auditor Ratification
✓ FORAuditor
Ernst & Young LLP
Tenure
N/A
Audit Fees
$8,122,159
Non-Audit Fees
$193,105
Non-audit fees (tax services of $193,105) represent only about 2.4% of audit fees ($8,122,159), far below the 50% threshold that would raise independence concerns. Auditor tenure is not explicitly disclosed in the proxy so the tenure trigger cannot fire per policy. Ernst & Young is a Big 4 firm fully appropriate for a company of CME's size and complexity.
Overall Assessment
CME Group's 2026 annual meeting presents a clean ballot with no significant governance red flags — the company delivered record financial results in 2025, its stock outperformed the disclosed compensation peer group over three years, and executive pay is strongly linked to performance outcomes. All standard proposals (director elections, auditor ratification, and say-on-pay) receive FOR votes, as do the board-proposed charter amendments that eliminate special Class B member director election rights, representing a meaningful pro-shareholder governance improvement.
Compensation Peer Group
15 companies disclosed in 2026 proxy filing